{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T12:22:06Z","timestamp":1789820526512,"version":"4.0.1"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100017585","name":"First Hospital of Jilin University","doi-asserted-by":"publisher","award":["JDYY-TRP-2025002"],"award-info":[{"award-number":["JDYY-TRP-2025002"]}],"id":[{"id":"10.13039\/501100017585","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82202879"],"award-info":[{"award-number":["82202879"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007847","name":"Natural Science Foundation of Jilin Province","doi-asserted-by":"publisher","award":["YDZJ202301ZYTS100"],"award-info":[{"award-number":["YDZJ202301ZYTS100"]}],"id":[{"id":"10.13039\/100007847","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics: X"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ijpx.2026.100492","type":"journal-article","created":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T07:55:33Z","timestamp":1769500533000},"page":"100492","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Tumor-responsive PEGylated mesoporous nanoparticles achieve enhanced chemotherapy and reduced toxicity in prostate cancer"],"prefix":"10.1016","volume":"11","author":[{"given":"Yangyang","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jixue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpx.2026.100492_bb0005","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s42247-020-00109-x","article-title":"Recent advances in stimuli-responsive drug release and targeting concepts using mesoporous silica nanoparticles","volume":"3","author":"Abdo","year":"2020","journal-title":"Emerg. Mater."},{"key":"10.1016\/j.ijpx.2026.100492_bb0010","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/s41467-017-00600-w","article-title":"Mechanistic understanding of in vivo protein corona formation on polymeric nanoparticles and impact on pharmacokinetics","volume":"8","author":"Bertrand","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijpx.2026.100492_bb0015","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.micromeso.2009.11.015","article-title":"Bio-degradation study of colloidal mesoporous silica nanoparticles: effect of surface functionalization with organo-silanes and poly (ethylene glycol)","volume":"132","author":"Cauda","year":"2010","journal-title":"Microporous Mesoporous Mater."},{"key":"10.1016\/j.ijpx.2026.100492_bb0020","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jconrel.2013.01.001","article-title":"Redox and pH-responsive degradable micelles for dually activated intracellular anticancer drug release","volume":"169","author":"Chen","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpx.2026.100492_bb0025","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jconrel.2011.01.030","article-title":"Glutathione-responsive nano-vehicles as a promising platform for targeted intracellular drug and gene delivery","volume":"152","author":"Cheng","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpx.2026.100492_bb0030","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1158\/1535-7163.MCT-09-0899","article-title":"Endocytosis of PEGylated agents enhances cancer imaging and anticancer efficacy","volume":"9","author":"Chuang","year":"2010","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.ijpx.2026.100492_bb0035","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.1021\/am3005225","article-title":"Mesoporous silica nanoparticles capped with disulfide-linked PEG gatekeepers for glutathione-mediated controlled release","volume":"4","author":"Cui","year":"2012","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.ijpx.2026.100492_bb0040","first-page":"10","article-title":"Nanoparticle-based drug delivery systems for cancer therapy","volume":"1","author":"Dang","year":"2020","journal-title":"Smart Mater. Med."},{"key":"10.1016\/j.ijpx.2026.100492_bb0045","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.drup.2014.04.001","article-title":"Nanoways to overcome docetaxel resistance in prostate cancer","volume":"17","author":"Ganju","year":"2014","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.ijpx.2026.100492_bb0050","doi-asserted-by":"crossref","first-page":"59576","DOI":"10.1039\/C5RA09774F","article-title":"Redox-sensitive mesoporous silica nanoparticles functionalized with PEG through a disulfide bond linker for potential anticancer drug delivery","volume":"5","author":"Gong","year":"2015","journal-title":"RSC Adv."},{"key":"10.1016\/j.ijpx.2026.100492_bb0055","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1126\/science.8128245","article-title":"Biodegradable long-circulating polymeric nanospheres","volume":"263","author":"Gref","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.ijpx.2026.100492_bb0060","doi-asserted-by":"crossref","first-page":"5845","DOI":"10.1039\/c0jm03851b","article-title":"Mesoporous silica nanoparticle based nano drug delivery systems: synthesis, controlled drug release and delivery, pharmacokinetics and biocompatibility","volume":"21","author":"He","year":"2011","journal-title":"J. Mater. Chem."},{"key":"10.1016\/j.ijpx.2026.100492_bb0065","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/smll.201001459","article-title":"In vivo biodistribution and urinary excretion of mesoporous silica nanoparticles: effects of particle size and PEGylation","volume":"7","author":"He","year":"2011","journal-title":"Small"},{"key":"10.1016\/j.ijpx.2026.100492_bb0070","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.biomaterials.2009.09.060","article-title":"The effect of the shape of mesoporous silica nanoparticles on cellular uptake and cell function","volume":"31","author":"Huang","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijpx.2026.100492_bb0075","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s13346-019-00631-4","article-title":"PEGylation: a promising strategy to overcome challenges to cancer-targeted nanomedicines: a review of challenges to clinical transition and promising resolution","volume":"9","author":"Hussain","year":"2019","journal-title":"Drug Delivery Transl. Res."},{"key":"10.1016\/j.ijpx.2026.100492_bb0080","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/s13046-020-01723-7","article-title":"Synergistic antitumor interaction of valproic acid and simvastatin sensitizes prostate cancer to docetaxel by targeting CSCs compartment via YAP inhibition","volume":"39","author":"Iannelli","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.ijpx.2026.100492_bb0085","doi-asserted-by":"crossref","first-page":"1907035","DOI":"10.1002\/adma.201907035","article-title":"Nanoarchitectured structure and surface biofunctionality of mesoporous silica nanoparticles","volume":"32","author":"Kankala","year":"2020","journal-title":"Adv. Mater."},{"key":"10.1016\/j.ijpx.2026.100492_bb0090","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.renene.2019.05.118","article-title":"Polyethylene glycol\/silica (PEG@ SiO2) composite inspired by the synthesis of mesoporous materials as shape-stabilized phase change material for energy storage","volume":"145","author":"Li","year":"2020","journal-title":"Renew. Energy"},{"key":"10.1016\/j.ijpx.2026.100492_bb0095","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1002\/smll.201000538","article-title":"Biocompatibility, biodistribution, and drug-delivery efficiency of mesoporous silica nanoparticles for cancer therapy in animals","volume":"6","author":"Lu","year":"2010","journal-title":"Small"},{"key":"10.1016\/j.ijpx.2026.100492_bb0100","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/1476-4598-8-68","article-title":"Docetaxel-induced prostate cancer cell death involves concomitant activation of caspase and lysosomal pathways and is attenuated by LEDGF\/p75","volume":"8","author":"Mediavilla-Varela","year":"2009","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ijpx.2026.100492_bb0105","doi-asserted-by":"crossref","first-page":"4539","DOI":"10.1021\/nn100690m","article-title":"Engineered design of mesoporous silica nanoparticles to deliver doxorubicin and P-glycoprotein siRNA to overcome drug resistance in a cancer cell line","volume":"4","author":"Meng","year":"2010","journal-title":"ACS Nano"},{"key":"10.1016\/j.ijpx.2026.100492_bb0110","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ijpharm.2005.10.010","article-title":"Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles","volume":"307","author":"Owens","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpx.2026.100492_bb0115","doi-asserted-by":"crossref","first-page":"1800020","DOI":"10.1002\/adbi.201800020","article-title":"Mesoporous silica nanoparticles for targeted and stimuli-responsive delivery of chemotherapeutics: a review","volume":"2","author":"Rahikkala","year":"2018","journal-title":"Adv. Biosyst."},{"key":"10.1016\/j.ijpx.2026.100492_bb0120","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1001\/jama.2025.0228","article-title":"Prostate cancer: a review","volume":"333","author":"Raychaudhuri","year":"2025","journal-title":"JAMA"},{"key":"10.1016\/j.ijpx.2026.100492_bb0125","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1039\/c0nr00156b","article-title":"Towards multifunctional, targeted drug delivery systems using mesoporous silica nanoparticles\u2013opportunities & challenges","volume":"2","author":"Rosenholm","year":"2010","journal-title":"Nanoscale"},{"key":"10.1016\/j.ijpx.2026.100492_bb0130","first-page":"676","article-title":"Molecular mechanisms of docetaxel resistance in prostate cancer","volume":"3","author":"Sekino","year":"2020","journal-title":"Cancer Drug Resist."},{"key":"10.1016\/j.ijpx.2026.100492_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124024","article-title":"PEGylated mesoporous silica core\u2013shell redox-responsive nanoparticles for delivering paclitaxel to breast cancer cells","volume":"655","author":"Shahbaz","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpx.2026.100492_bb0140","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.yexmp.2008.12.004","article-title":"Nanoparticle-based targeted drug delivery","volume":"86","author":"Singh","year":"2009","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.ijpx.2026.100492_bb0145","doi-asserted-by":"crossref","first-page":"177","DOI":"10.17485\/ijst\/2011\/v4i3.16","article-title":"Nanoparticle based drug delivery system: advantages and applications","volume":"4","author":"Singh","year":"2011","journal-title":"Indian J. Sci. Technol."},{"key":"10.1016\/j.ijpx.2026.100492_bb0150","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3390\/molecules23010047","article-title":"Mesoporous silica nanoparticles for drug delivery: current insights","volume":"23","author":"Vallet-Reg\u00ed","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.ijpx.2026.100492_bb0155","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ijpharm.2011.04.023","article-title":"Docetaxel-loaded-lipid-based-nanosuspensions (DTX-LNS): preparation, pharmacokinetics, tissue distribution and antitumor activity","volume":"413","author":"Wang","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpx.2026.100492_bb0160","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ejps.2015.02.008","article-title":"Redox-responsive mesoporous silica as carriers for controlled drug delivery: a comparative study based on silica and PEG gatekeepers","volume":"72","author":"Wang","year":"2015","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpx.2026.100492_bb0165","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1002\/smll.201101613","article-title":"Engineered redox-responsive PEG detachment mechanism in PEGylated nano-graphene oxide for intracellular drug delivery","volume":"8","author":"Wen","year":"2012","journal-title":"Small"},{"key":"10.1016\/j.ijpx.2026.100492_bb0170","doi-asserted-by":"crossref","first-page":"9972","DOI":"10.1039\/c1cc11760b","article-title":"Mesoporous silica nanoparticles as nanocarriers","volume":"47","author":"Wu","year":"2011","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ijpx.2026.100492_bb0175","doi-asserted-by":"crossref","first-page":"3862","DOI":"10.1039\/c3cs35405a","article-title":"Synthesis of mesoporous silica nanoparticles","volume":"42","author":"Wu","year":"2013","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.ijpx.2026.100492_bb0180","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/09205063.2015.1107708","article-title":"The properties of mesoporous silica nanoparticles functionalized with different PEG-chain length via the disulfide bond linker and drug release in glutathione medium","volume":"27","author":"Xie","year":"2016","journal-title":"J. Biomater. Sci. Polym. Ed."},{"key":"10.1016\/j.ijpx.2026.100492_bb0185","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.914875","article-title":"Causes of death among prostate cancer patients aged 40 years and older in the United States","volume":"12","author":"Ye","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ijpx.2026.100492_bb0190","doi-asserted-by":"crossref","first-page":"2408898","DOI":"10.1002\/smll.202408898","article-title":"Smart Mesoporous Silica Nanoparticles in Cancer: Diagnosis, Treatment, Immunogenicity, and Clinical translation","volume":"21","author":"Yousefiasl","year":"2025","journal-title":"Small"},{"key":"10.1016\/j.ijpx.2026.100492_bb0195","doi-asserted-by":"crossref","first-page":"18179","DOI":"10.1021\/acsami.5b05893","article-title":"Polymer-coated hollow mesoporous silica nanoparticles for triple-responsive drug delivery","volume":"7","author":"Zhang","year":"2015","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.ijpx.2026.100492_bb0200","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.micromeso.2010.11.013","article-title":"PEGylated hollow mesoporous silica nanoparticles as potential drug delivery vehicles","volume":"141","author":"Zhu","year":"2011","journal-title":"Microporous Mesoporous Mater."}],"container-title":["International Journal of Pharmaceutics: X"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590156726000101?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590156726000101?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T03:33:14Z","timestamp":1785209594000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590156726000101"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":40,"alternative-id":["S2590156726000101"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpx.2026.100492","relation":{},"ISSN":["2590-1567"],"issn-type":[{"value":"2590-1567","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumor-responsive PEGylated mesoporous nanoparticles achieve enhanced chemotherapy and reduced toxicity in prostate cancer","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics: X","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpx.2026.100492","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100492"}}